Boston Scientific Corp. closed 9.34% short of its 52-week high of $107.17, which the company reached on February 5th.
The Boston Bruins have been at or near the 32nd-ranked prospect pool in the NHL for a few seasons. Currently, many hockey ...
Michael Arulfo, CPM, CLP, CSPO, has built a distinguished career at the intersection of enterprise architecture and ...
Boston Scientific’s stock surged 40.6% in the past year, far outpacing the broader market. This growth stems from strong ...
The stock's fall snapped a two-day winning streak.
Diller Scofidio + Renfro is designing a new purpose-built home for the Frederick S. Pardee School for Global Studies at ...
Lila Sciences has secured $200 million in seed funding from Flagship Pioneering, which incubated the company, and General ...
Zacks Investment Research on MSN1d
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...
In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.
Boston Scientific closed at $95.52, rising 1.48% while the broader market declined. The S&P 500 fell 0.76%, the Dow dropped 1 ...
Zacks Investment Research on MSN2d
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-TermIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Boston Mayor Michelle Wu is getting heat over her testimony to Congress over Boston's 'sanctuary city' status.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback